These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37305125)

  • 1. Case report: Successful immunomodulators combined with electromagnetic field therapy in a patient with methazolamide-induced Steven Johnson syndrome/toxic epidermal necrolysis overlap.
    Zhang N; Su T; Yan J; Zhang M; Zhao S; Liu C; Chen T
    Front Med (Lausanne); 2023; 10():1192920. PubMed ID: 37305125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methazolamide Associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Female of Caucasian Descent.
    Baluch A; Chohan MR; Warda K; Sippy R; Sandhu J
    Cureus; 2022 Feb; 14(2):e21864. PubMed ID: 35155038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
    Tangamornsuksan W; Lohitnavy M
    Pharmacogenomics J; 2019 Jun; 19(3):286-294. PubMed ID: 30242287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.
    Yang F; Xuan J; Chen J; Zhong H; Luo H; Zhou P; Sun X; He L; Chen S; Cao Z; Luo X; Xing Q
    Pharmacogenomics J; 2016 Feb; 16(1):83-7. PubMed ID: 25918017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
    Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
    Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
    J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
    Xiong H; Wang L; Jiang M; Chen S; Yang F; Zhu H; Zhu Q; Tang C; Qin S; Xing Q; Luo X
    Mol Immunol; 2019 Feb; 106():170-177. PubMed ID: 30623817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK
    Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unusual Case of Stevens-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome in HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Breast Cancer Patient Treated With Docetaxel.
    Shamloul G; Desai M; Laslett N
    Cureus; 2023 Apr; 15(4):e37590. PubMed ID: 37193463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma.
    Tahseen AI; Patel NB
    JAAD Case Rep; 2018 Oct; 4(9):930-933. PubMed ID: 30320198
    [No Abstract]   [Full Text] [Related]  

  • 16. Unique motif shared by HLA-B*59:01 and HLA-B*55:02 is associated with methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    Jiang M; Yang F; Zhang L; Xu D; Jia Y; Cheng Y; Han S; Wang T; Chen Z; Su Y; Zhu Z; Chen S; Zhang J; Wang L; Yang L; Yang J; Luo X; Xing Q
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):873-880. PubMed ID: 35122707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carrying HLA-B*59:01.
    Shu C; Shu D; Tie D; Yu M; Zhang R; Wang T; Dong Q; Sun Q; Mao X; Yan Y
    Int J Dermatol; 2015 Nov; 54(11):1242-5. PubMed ID: 25970075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.